Ray Dalio
MED icon

Ray Dalio’s Medifast MED Stock Holding History

Ray Dalio’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,461
Closed -$669K – 916
2024
Q1 		$669K Sell
17,461
-2,449
-12% -$119K ﹤0.01% 600
2023
Q4 		$1.34M Sell
19,910
-2,016
-9% -$140K 0.01% 594
2023
Q3 		$1.64M Buy
21,926
+1,017
+5% +$90.2K 0.01% 527
2023
Q2 		$1.93M Sell
20,909
-1,271
-6% -$113K 0.01% 464
2023
Q1 		$2.3M Sell
22,180
-648
-3% -$71.8K 0.01% 436
2022
Q4 		$2.63M Sell
22,828
-7,577
-25% -$882K 0.01% 486
2022
Q3 		$3.29M Sell
30,405
-13,714
-31% -$1.97M 0.02% 464
2022
Q2 		$7.96M Buy
44,119
+13,688
+45% +$2.45M 0.03% 381
2022
Q1 		$5.2M Buy
30,431
+7,011
+30% +$1.32M 0.02% 459
2021
Q4 		$4.91M Buy
23,420
+3,044
+15% +$629K 0.03% 300
2021
Q3 		$3.92M Sell
20,376
-594
-3% -$146K 0.02% 326
2021
Q2 		$5.93M Buy
+20,970
New +$5.68M 0.04% 302

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Ray Dalio's MED Position: Q2 2024 in Review

Ray Dalio sold out of Medifast (MED) in Q2 2024, closing a stake of 17,461 shares — an estimated $669K sold.

Ray Dalio first reported a position in MED in Q2 2021 and held it in 12 quarters. The position peaked at $7.96M in Q2 2022. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Ray Dalio reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Ray Dalio sold 17,461 Medifast shares in Q2 2024, an estimated $669K.
  • Ray Dalio first reported a position in Medifast in Q2 2021 and held it in 12 quarters.
  • Ray Dalio's Medifast position peaked at $7.96M in Q2 2022.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Bridgewater Associates's 13F filing for Q2 2024, filed 14 Aug 2024.